Clinical Trials Logo

SCHIZOPHRENIA 1 (Disorder) clinical trials

View clinical trials related to SCHIZOPHRENIA 1 (Disorder).

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT01832285 Recruiting - Clinical trials for SCHIZOPHRENIA 1 (Disorder)

Effect of Fluvoxamine on Cognition, Behavior, Symptoms and mRNA and Protein Expression in Schizophrenia Patients

Start date: December 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to determine effect of Fluvoxamine augmentation on cognitive function , aggressive behavior , clinical symptoms and mRNA (messenger ribonucleic acid) and protein expression in human peripheral mononuclear blood cells (PMC) in medicated schizophrenia patients